Medications for Cytomegalovirus Retinitis

9 results

  • Foscavir (foscarnet sodium)

    (foscarnet sodium)
    Clinigen Limited
    Usage: FOSCAVIR is indicated for treating CMV retinitis in AIDS patients and for acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients. Its safety and efficacy are not established for other CMV or HSV infections, or in nonimmunocompromised individuals.

  • Ganciclovir (ganciclovir sodium)

    (ganciclovir sodium)
    Hainan Poly Pharm. Co., Ltd.
    Usage: Ganciclovir for Injection is indicated for the treatment of cytomegalovirus (CMV) retinitis in immunocompromised adults, including those with AIDS, and for the prevention of CMV disease in adult transplant recipients at risk for this condition.

  • Ganciclovir (ganciclovir)

    (GANCICLOVIR)
    Ranbaxy Pharmaceuticals Inc.
    Usage: Ganciclovir capsules are indicated for the prevention of CMV disease in solid organ transplant recipients and advanced HIV patients at risk. They serve as an alternative to intravenous treatment for maintenance of stable CMV retinitis in immunocompromised patients, not for congenital CMV or non-immunocompromised individuals.

  • Ganciclovir sodium (ganciclovir sodium)

    (ganciclovir sodium)
    Slate Run Pharmaceuticals, LLC
    Usage: Ganciclovir for Injection is indicated for treating cytomegalovirus (CMV) retinitis in immunocompromised adults, including those with AIDS, and for preventing CMV disease in at-risk adult transplant recipients.

  • Valcyte (valganciclovir)

    (valganciclovir)
    Genentech, Inc.
    Usage: VALCYTE is indicated for the treatment of cytomegalovirus (CMV) retinitis in adults with AIDS. It also prevents CMV disease in high-risk transplant patients: kidney, heart, and kidney-pancreas recipients, as well as pediatric kidney and heart transplant patients aged 1 month to 16 years.

  • Valganciclovir (valganciclovir)

    (Valganciclovir)
    Ajanta Pharma USA Inc.
    Usage: Valganciclovir tablets are indicated for treating Cytomegalovirus (CMV) retinitis in AIDS patients and for preventing CMV disease in high-risk kidney, heart, and kidney-pancreas transplant recipients. It is also used in pediatric patients aged 1 month to 16 years for preventing CMV disease post-transplant.

  • Valganciclovir (valganciclovir)

    (Valganciclovir)
    Golden State Medical Supply, Inc.
    Usage: Valganciclovir tablets are indicated for treating cytomegalovirus (CMV) retinitis in HIV/AIDS patients and for preventing CMV disease in high-risk kidney, heart, and kidney-pancreas transplant patients (adults) as well as in high-risk kidney and heart transplant pediatric patients aged 1 month to 16 years.

  • Valganciclovir hydrochloride (valganciclovir hydrochloride)

    (Valganciclovir hydrochloride)
    Ajanta Pharma USA Inc.
    Usage: Valganciclovir is indicated for treating cytomegalovirus (CMV) retinitis in AIDS patients and for preventing CMV disease in high-risk transplant recipients (adults and pediatric patients) including kidney and heart transplants.

  • Vistide (cidofovir)

    (CIDOFOVIR)
    Gilead Sciences Inc
    Usage: VISTIDE is indicated for treating CMV retinitis in patients with AIDS. Its safety and efficacy have not been established for other CMV infections, congenital or neonatal CMV disease, or CMV disease in non-HIV-infected individuals.